Request for Applications (RFA)
Station 41: Therapeutics Development Fund
Are you a founder or PI with an early-stage (Technology Readiness Level 1-4) therapeutic product? Southern Research is launching the Therapeutics Development Fund to support participating startups and innovators with technical and entrepreneurial support.
Learn how Technology Readiness Levels are defined by the Department of Health and Human Services.
To be eligible for the program, the following criteria are required. You must be:
Intent and Commitment to Alabama
Pending a positive set of outcomes from studies completed through this fund mechanism, companies must sign a non-binding Letter of Commitment to grow biotechnology jobs in Alabama in accordance with Innovate Alabama’s goals with its novel tax credit program. The plans in this letter include:
With support from Innovate Alabama, Southern Research’s Therapeutics Development Fund invests between $300k to $500k via in-kind technical and commercialization assistance for equity to bridge the gap to critical sources of follow-on funding, such as angel and venture capital and industry partnerships.
Technical and entrepreneurial services include:
High-Throughput Screening
Chemistry
Biodistribution and Toxicology
Pharmacokinetic (PK) and ADME
Legal Counsel
Venture Capital Training and Coaching
Mentorship
Wet Lab Space and Shared Equipment
We seek broad and flexible spectrum of early-stage/preclinical companies to support a diversified portfolio of projects. Projects will be accepted across a range of therapeutic areas and modalities, and will ultimately be selected to align with Southern Research’s technical capabilities.
Investment terms will be determined indiviudually with successful participants. Investments may take the form of direct equity, convertible notes, milestones, shared IP interest, or other mechanisms. We will work with you to identify the mechanism best suited for your product and company.
Disclaimers
Please review our privacy policy before sharing confidential information
Please be comprehensive to allow us to understand your project and technology fully.
Please also address the status of IP protection.
Please also indicate all prior funding for your project and technology.
Process
Upon receipt of your application, our Scientific and Commercialization teams will review and process your materials within 30 days or less of the application date. From there, the team will determine whether the applicant meets our desired criteria or if the application requires additional information. If selected, a formal onboarding process will be scheduled with the applicant.
Ready to Apply?
Southern Research is launching the Therapeutics Development Fund to support participating startups and innovators with technical and entrepreneurial support.
Contact Us
"*" indicates required fields